Freeman, M., Betts, K. A., Jiang, S., Du, E. X., Gupte-Singh, K., Lu, Y., . . . Shoushtari, A. N. (2019). Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data. Adv Ther.
Stile di citazione ChicagoFreeman, Morganna, Keith A. Betts, Shan Jiang, Ella X. Du, Komal Gupte-Singh, Yichen Lu, Sumati Rao, e Alexander N. Shoushtari. "Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab As Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data." Adv Ther 2019.
Citazione MLAFreeman, Morganna, et al. "Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab As Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data." Adv Ther 2019.